Minnesota Advanced Practice Nurse CE Package
This convenient 30-hour package of CE courses (including 25 advanced pharmacology hours) is designed specifically to help Minnesota Advanced Practice Nurses meet their requirements for license renewal. Included is an 8-hour course to meet the Drug Enforcement Administration (DEA)’s new training requirement under the Medication Access and Training Expansion (MATE) Act.
Included Courses
Courses included in this package. Click on a course to learn more.
- Clinical Management of Substance Use Disorders 5 5
Course release date: 7/10/2023
About the Course
Substance use and abuse cost society more than $740 billion annually in workplace productivity, healthcare, and crime-related expenses (NIDA, 2020). Substance use disorders are complex phenomena affecting individuals' and families’ lives. This course reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. The course also examines federal and state-controlled substance regulations and the prescribing practices for controlled substances. The focus is on clinical and safety considerations by nurse practitioners when prescribing non-cancer-related opioid medications for acute/chronic pain. - Identifying Common Rashes in Urgent Care: A Case Study Approach for APRNs 4 2
Course release date: 7/10/2023
Family nurse practitioners (FNPs) and emergency nurse practitioners (ENPs) care for patients with many ailments in the emergency department (ED). The purpose of this course is to characterize the most common dermatologic diagnoses in the urgent care setting. The goal is to build provider confidence in assessing, diagnosing, and treating rashes in the urgent care setting.
Preview this course before you buy: Click to view the CE course eBook
- Management of Atrial Fibrillation for APRNs 2 2Course release date: 4/5/2022
About the Course
Atrial fibrillation is a common healthcare problem. This course reviews the concepts of cardiac output, risk factors for atrial fibrillation (AF), classifications of AF, the pearls of obtaining a history and physical of a patient with AF, diagnostic testing, and the overall implications for pharmacologic management. APRN prescribing considerations and evidence-based practice guidelines are included in this course.Preview this course before you buy: Click to view the CE course eBook
- Pain Management: Evidence-Based Guidance for Prescribing Opioids 5 5
Course release date: 6/12/2023
About the Course
This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances, including drug diversion. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Pharmacological Management: Type 1 Diabetes in Children, 2nd Edition 3 3Course release date: 12/21/2022
About the Course
The purpose of this course is to review diagnostic criteria, insulin pharmacokinetics and dosing strategies, hypoglycemia management, and psychosocial considerations in the pediatric type 1 diabetes mellitus patient. Diabetes is one of the most common chronic diseases in pediatric patients, and newly diagnosed cases are on the rise. Management of type 1 diabetes mellitus requires specialized knowledge and individualized treatment plans. All pediatric healthcare professionals should be equipped to help patients achieve glycemic control through optimized therapy and continual education.Preview this course before you buy: Click to view the CE course eBook
- Prescribing Controlled Substances Safely: A DEA Requirement 8 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- Using Evidence in Clinical Nursing Practice, 2nd Edition 3Course release date: 3/24/2022About the Course
Evidence-based practice (EBP) relies on scientific research findings to modify or develop policies and procedures that incorporate the latest evidence into clinical practice. The purpose of this course is to help nurses incorporate nursing research findings into their practice for the maximum benefit of patients and the facilitation of professional growth and development.Preview this course before you buy: Click to view the CE course eBook